3Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol, 2005, 1011: 373- 382.
4Fanigliulo I.. Comparato G, Aragona G. et al. Role of gut microflora and probiotic effects in the irritable bowel syndrome. Acta Biomed. 2006. 77:85-89.
5Drouault-Holowaez S, Bieuvelet S, Burckel A, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol, 2008, 32:147-152.
6Nobaek S, Johansson ML, Molin G, et al. Alteration of intes tinal microflora is associated with reduction in abdominal bloa ring and pain in patients with irritable bowel syndrome. Am J Gastroenterol,2000,95:1231-1238.
7Whorwell PJ, Altinger 1., Morel J, et al. Efficacy of an encap sulated probiotic bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gaslroenterol, 2006, 101:1581-1590.
8Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care; a muhieentre, randomized, double blind, controlled trial. Aliment Pharmacol Ther, 2007,26: 475-486.
9Biltner AC,Croffut RM. Stranahan MC. et al. Prescript-assist probiotic-prebiotic treatment for irritable bowel syndrome: a lly oriented, 2-week. randomized, placebo-con le blind clinical study. Clin Ther. 2005, 27.755 -761.
10Biuner AC. Crofful RM. Stranahan MC. et al. Prescript assist probiotic prebiotic treatment for irritable bowel syndrome: an open-label, partially controlled. 1 year extension of a previously published cnntrollcd clinical trial. Clin Ther. 2007, 29:1153-1160.
8Chang FY,Lu CL. Irritable bowel syndrome in the 21sr century:perspectives from Asia or South-east Asia[J].Journal of Gastroenterology and Hepatology,2007,(01):4-12.
9CUI S,HU Y. Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebocontrolled study[J].lnt J Clin Exp Med,2012,(03):238-244.
10Guglielmetii S,Mora G,schwender M. Randomised clinical trial:Bifidobocteriuni bifulum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-a double-blind,placebo-controlled study[J].Alimentary Pharmacology and Therapeutics,2011,(10):1123-1132.
